These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 10613340)

  • 1. Oral contraceptives as risk factors for cervical adenocarcinomas and squamous cell carcinomas.
    Lacey JV; Brinton LA; Abbas FM; Barnes WA; Gravitt PE; Greenberg MD; Greene SM; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Silverberg SG; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1079-85. PubMed ID: 10613340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix.
    Lacey JV; Brinton LA; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
    Gynecol Oncol; 2000 Apr; 77(1):149-54. PubMed ID: 10739704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity as a potential risk factor for adenocarcinomas and squamous cell carcinomas of the uterine cervix.
    Lacey JV; Swanson CA; Brinton LA; Altekruse SF; Barnes WA; Gravitt PE; Greenberg MD; Hadjimichael OC; McGowan L; Mortel R; Schwartz PE; Kurman RJ; Hildesheim A
    Cancer; 2003 Aug; 98(4):814-21. PubMed ID: 12910527
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cancer of the cervix, papillomavirus, contraception and tobacco].
    Thiry L; Vokaer R; Detremmerie O; De Schepper N; Herzog A; Bollen A
    J Gynecol Obstet Biol Reprod (Paris); 1993; 22(5):477-86. PubMed ID: 8228010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-risk and multiple human papillomavirus infections associated with cervical abnormalities in Japanese women.
    Sasagawa T; Basha W; Yamazaki H; Inoue M
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):45-52. PubMed ID: 11205488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A case-control study of risk factors for invasive cervical cancer among U.S. women exposed to oncogenic types of human papillomavirus.
    Shields TS; Brinton LA; Burk RD; Wang SS; Weinstein SJ; Ziegler RG; Studentsov YY; McAdams M; Schiffman M
    Cancer Epidemiol Biomarkers Prev; 2004 Oct; 13(10):1574-82. PubMed ID: 15466972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population-based study of squamous cell vaginal cancer: HPV and cofactors.
    Daling JR; Madeleine MM; Schwartz SM; Shera KA; Carter JJ; McKnight B; Porter PL; Galloway DA; McDougall JK; Tamimi H
    Gynecol Oncol; 2002 Feb; 84(2):263-70. PubMed ID: 11812085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix.
    Madeleine MM; Daling JR; Schwartz SM; Shera K; McKnight B; Carter JJ; Wipf GC; Critchlow CW; McDougall JK; Porter P; Galloway DA
    Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):171-7. PubMed ID: 11303584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Types of human papillomavirus revealed in cervical adenocarcinomas after DNA sequencing.
    Andersson S; Rylander E; Larson B; Sigurdardottir S; Backlund I; Sällström J; Wilander E
    Oncol Rep; 2003; 10(1):175-9. PubMed ID: 12469166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HPV co-factors related to the development of cervical cancer: results from a population-based study in Costa Rica.
    Hildesheim A; Herrero R; Castle PE; Wacholder S; Bratti MC; Sherman ME; Lorincz AT; Burk RD; Morales J; Rodriguez AC; Helgesen K; Alfaro M; Hutchinson M; Balmaceda I; Greenberg M; Schiffman M
    Br J Cancer; 2001 May; 84(9):1219-26. PubMed ID: 11336474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
    Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
    Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The relationship with human papilloma virus DNA in cervical adenocarcinoma].
    Ogura K; Ishi K; Suzuki F; Suto H; Kina K; Koyatsu J; Nojima M; Yoshida K; Suda K
    Rinsho Byori; 2004 Feb; 52(2):115-9. PubMed ID: 15027314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of cervical cancer by cell type.
    Brinton LA; Tashima KT; Lehman HF; Levine RS; Mallin K; Savitz DA; Stolley PD; Fraumeni JF
    Cancer Res; 1987 Mar; 47(6):1706-11. PubMed ID: 3815368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution of human papillomavirus types 16 and 18 variants in squamous cell carcinomas and adenocarcinomas of the cervix.
    Burk RD; Terai M; Gravitt PE; Brinton LA; Kurman RJ; Barnes WA; Greenberg MD; Hadjimichael OC; Fu L; McGowan L; Mortel R; Schwartz PE; Hildesheim A
    Cancer Res; 2003 Nov; 63(21):7215-20. PubMed ID: 14612516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prospective study showing long-term infection with human papillomavirus 16 before the development of cervical carcinoma in situ.
    Ylitalo N; Josefsson A; Melbye M; Sörensen P; Frisch M; Andersen PK; Sparén P; Gustafsson M; Magnusson P; Pontén J; Gyllensten U; Adami HO
    Cancer Res; 2000 Nov; 60(21):6027-32. PubMed ID: 11085523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus type distribution in cervical cancer in Delhi, India.
    Bhatla N; Dar L; Patro AR; Kriplani A; Gulati A; Verma K; Broor S; Shah KV; Gravitt PE
    Int J Gynecol Pathol; 2006 Oct; 25(4):398-402. PubMed ID: 16990719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cervix uteri lesions and human papiloma virus infection (HPV): detection and characterization of DNA/HPV using PCR (polymerase chain reaction].
    Serra H; Pista A; Figueiredo P; Urbano A; Avilez F; De Oliveira CF
    Acta Med Port; 2000; 13(4):181-92. PubMed ID: 11155485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The presence of high-risk HPV combined with specific p53 and p16INK4a expression patterns points to high-risk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix.
    Zielinski GD; Snijders PJ; Rozendaal L; Daalmeijer NF; Risse EK; Voorhorst FJ; Jiwa NM; van der Linden HC; de Schipper FA; Runsink AP; Meijer CJ
    J Pathol; 2003 Dec; 201(4):535-43. PubMed ID: 14648656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer.
    Madeleine MM; Shera K; Schwartz SM; Daling JR; Galloway DA; Wipf GC; Carter JJ; McKnight B; McDougall JK
    Cancer Epidemiol Biomarkers Prev; 2000 Feb; 9(2):225-7. PubMed ID: 10698487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.